The FDA granted marketing authorization for the ProSense Cryoablation System for small, early-stage breast cancer in older ...

The cryoablation treatment is indicated for women aged 70 and above with early-stage, low-risk breast tumours.

Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi were awarded the prize for research showing how the body regulates its ...

IceCure receives US FDA marketing authorization for ProSense cryoablation to treat low-risk breast cancer in women aged 70 and above: Caesarea, Israel Monday, October 6, 2025, 11: ...

The market is in a phase of rapid advancement, driven by expanding indications and new technology. A strong focus on ...

Bremelanotide, also known by its research designation PT-141, is a synthetic cyclic heptapeptide derived from the ...

IceCure Medical ICCM recently received FDA marketing authorization for its ProSense cryoablation system, marking the first ...

Three scientists won the Nobel Prize in medicine Monday for discoveries about how the immune system works. In separate ...

According to Towards Chemical and Materials, the global petrochemical market size is calculated at USD 700.05 billion in 2025 ...

The Nobel Prize in Medicine was awarded on Monday to three scientists for discovering how a particular kind of cell can stop ...

Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi discovered cells that protect the body from autoimmune diseases.

Using fruit flies as a model species, researchers will study how individual differences in genetic background and diet can influence susceptibility to metabolic diseases.